# FDA Inspection 958960 - Mercy Health St. Mary's - February 11, 2016

Source: https://www.keypedia.com/records/fda_inspections/mercy-health-st-marys/7a498257-1db6-4782-8a32-54def18f6710
Source feed: FDA_Inspections

> FDA Inspection 958960 for Mercy Health St. Mary's on February 11, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 958960
- Company Name: Mercy Health St. Mary's
- Inspection Date: 2016-02-11
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1045294 - 2018-02-23](https://www.keypedia.com/records/fda_inspections/mercy-health-st-marys/9563277b-52d2-4f9d-b0db-1e418a1b2d2c)
- [FDA Inspection 847783 - 2013-09-05](https://www.keypedia.com/records/fda_inspections/mercy-health-st-marys/4d1272ae-9bd0-420e-b761-aa890dee3790)

Company: https://www.keypedia.com/companies/mercy-health-st-marys/1f6dcfdb-d3c6-468c-9def-2ccca7c03006

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d